Is a complete CAPR research report available?

No complete published report is available for Capricor Therapeutics, Inc. (CAPR) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Capricor Therapeutics, Inc. (CAPR)

NASDAQ: CAPR · USD

$4.19

-2.38 (-36.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first CAPR analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	242.7M
Net income (ttm)	-114.6M
EPS (ttm)	-$2.32
Shares out	57.9M
Volume	28,916,937
Beta	0.42
Price target	$40.1	+858.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -114.6M
EPS (ttm): -$2.32
Market cap: 242.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All CAPR indicators

Market & fundamental data

Available fields

188

Groups with data

Currency

USD

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001133869
Company name	Capricor Therapeutics, Inc.
Country	United States
Country code	US
Cusip	14070B309
Employees	231
Employees Change	71%
Employees Change Percent	44.38
Enterprise value	$-42.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US14070B3096
Last refreshed	2026-07-31
Market cap	$242.7M
Market cap category	Micro-Cap
Price	$4.19
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	CAPR
Website	https://www.capricor.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-51.8%
FCF yield	-51.52%
P/B ratio	1.36x
PS Forward	1.77x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-92.9M
Net Income	$-114.6M
Net Income Growth Years	0%
Profit Per Employee	$-496,077
ROA	-31.23
Roa5y	-30.32
ROCE	-40.98
ROE	-56.4
Roe5y	-85.21
ROIC	-35.49

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-19.58%
Cagr1y	-37.85%
Cagr3y	-2.57%
Cagr5y	-0.61%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$326.3M
Cash	$278.6M
Current Assets	$283.1M
Current Liabilities	$33.6M
Debt	$14.8M
Debt Equity	$0.05
Equity	$278.7M
Interest Coverage	-39.38
Liabilities	$47.6M
Long Term Assets	$43.2M
Long Term Liabilities	$13.9M
Net Cash	$263.8M
Net Cash By Market Cap	$119
Net Cash Growth	83.81%
Net Debt Equity	$-0.95
Tangible Book Value	$278.7M
Tangible Book Value Per Share	$4.83
WACC	7.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.42
Net Working Capital	$-28.3M
Quick ratio	8.28
Working Capital	$249.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-27.43%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-88.68%
1Y total return	-37.83%
200-day SMA	23.3
3Y total return	-7.51%
50-day SMA	24.03
50-day SMA vs 200-day SMA	50over200
5Y total return	-3.01%
All Time High	171.5
All Time High Change	-97.56%
All Time High Date	2014-01-22
All Time Low	0.88
All Time Low Change	376.14%
All Time Low Date	2020-03-12
ATR	2.44
Beta	0.42
Beta1y	0.8
Beta2y	2.3
Ch YTD	-85.48
High	4.21
High52	40.37
High52 Date	2025-12-03
High52ch	-89.62%
Low	2.96
Low52	2.96
Low52 Date	2026-07-30
Low52ch	41.55%
Ma50ch	-82.56%
Price vs 200-day SMA	-82.02%
RSI	11.68
RSI Monthly	41.24
RSI Weekly	24.16
Sharpe ratio	0.64x
Sortino ratio	2.7
Total Return	-27.43%
Tr YTD	-85.48
Tr1m	-82.39%
Tr1w	-78.87%
Tr3m	-87.09%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	5
Analyst Price Target Top	$21.5
Analyst Ratings	Buy
Analyst Ratings Top	Hold
Earnings EPS Estimate	$-0.59
Operating Income	$-119.9M
Price target	$40.14
Price Target Change	$858
Price Target Change Top	$413

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	48,549,316%
Float Percent	83.83%
Shares Insiders	1.04%
Shares Institutions	52.04%
Shares Out	57,911,893
Shares Qo Q	17.57%
Shares Yo Y	27.43%
Short Float	32.09%
Short Ratio	9.14
Short Shares	26.9

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-131.4M
Adjusted OCF	-110,036,548
Average Volume	5,106,722.8x
Bv Per Share	4.83
CAPEX	$-21.3M
Ch10y	-88.68
Ch1m	-82.39
Ch1w	-78.87
Ch1y	-37.83
Ch3m	-87.09
Ch3y	-7.51
Ch5y	-3.01
Ch6m	-81.47
Change	-36.23%
Change From Open	36.48
Close	6.57
Days Gap	-53.27
Depreciation Amortization	2,018,261
Dollar Volume	121,161,966
Earnings Date	2026-08-06
Earnings Time	amc
EBIT	$-119.9M
EBITDA	$-117.9M
EPS	$-2.32
F Score	2
FCF	$-114M
FCF EV Yield	267.51x
FCF Per Share	$-1.97
Financing CF	250,312,601
Fiscal Year End	December
Founded	2,005
Income Tax	$1,600
Investing CF	-81,052,988
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Date	2019-06-05
Last Split Type	Reverse
Last10k Filing Date	2026-03-17
Ma150	27.22
Ma150ch	-84.61%
Ma20	18.64
Ma20ch	-77.53%
Net CF	76,626,981
Next Earnings Date	2026-08-10
Open	3.07
Optionable	Yes
Position In Range	98.4
Post Close	4.19
Postmarket Change Percent	-5.25
Postmarket Price	$3.97
Ppne	41,661,117
Price Date	2026-07-30
Ptbv Ratio	0.79
Relative Volume	5.66x
Share Based Comp	17,403,916
Tr6m	-81.47%
Us State	California
Views	809
Volume	28,916,937

Capricor Therapeutics, Inc. (CAPR)

Coverage state: Market snapshot only — no published research

Generate the first CAPR analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · CAPR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CAPR indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on CAPR

Frequently asked questions